share_log

Lifequest’s Wholly Owned Subsidiary Receives First Order for 93,000 Gallons/Day Industrial Wastewater Treatment Plant for a Pharmaceutical Company

Lifequest’s Wholly Owned Subsidiary Receives First Order for 93,000 Gallons/Day Industrial Wastewater Treatment Plant for a Pharmaceutical Company

LifeQuest的全資子公司收到第一份訂單,為一家制藥公司購買93,000加侖/天的工業廢水處理廠
GlobeNewswire ·  2022/07/13 08:05

RIDGEFIELD PARK, NJ, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --LIFEQUEST WORLD CORP (LQWC) is focused on innovative, decentralized, scalable wastewater treatment and reuse technologies. Through its wholly owned subsidiary, Biopipe India Private Limited, the Company is concurrently pursuing both industrial and sewage wastewater treatment with JV partner Abrimix. Designed to be the primary treatment of a zero liquid discharge solution, the first treatment plant is to be established for a pharmaceutical company based out of Pune, India. 

新澤西州里奇菲爾德公園,2022年7月13日(Global Newswire)--通過NewMediaWire,LifeQuest World Corp(LQWC)專注於創新、分散、可擴展的廢水處理和再利用技術。通過其全資子公司Biopipe India Private Limited,該公司正在與合資夥伴AbriMix同時進行工業廢水和污水處理。設計用於零液體排放溶液的主要處理,將為印度浦那的一家制藥公司建立第一個處理廠。

Tanmay Pawale, the CEO of Biopipe India Private Limited, stated, "For the past one year we have been working to establish a foothold in the industrial wastewater treatment market in India and excited to have secured our first order from a highly reputable pharmaceutical company. The Abrimix ETP is a proven solution and getting the first plant operating will be a major milestone. We have developed a strong sales funnel and with our skid-mounted pilot plant expected to be ready soon, we will be able to prove the efficacy of Abrimix ETP in various industries, and especially for the most difficult to treat water. Zero liquid discharge is a rapidly growing approach where all, or most, of the water is recovered and reused, thereby minimizing effluent discharge. We expect to deliver and commission this plant within the next five months."  

Biopipe India Private Limited首席執行官TanMay Pawale表示:“在過去的一年裏,我們一直致力於在印度工業廢水處理市場站穩腳跟,並很高興從一家聲譽卓著的製藥公司獲得了我們的第一份訂單。AbriMix ETP是一個經過驗證的解決方案,第一個工廠投產將是一個重要的里程碑。我們已經開發了強大的銷售漏斗,我們的滑板式中試工廠預計很快就會準備就緒,我們將能夠在各個行業證明AbriMix ETP的有效性,特別是對於最難處理的水。液體零排放是一種快速發展的方法,即所有或大部分水被回收和再利用,從而將污水排放降至最低。我們預計在未來5個月內交付並投產這座工廠。“

Pieter Jansen, the Founder and CEO of Abrimix Pty Limited, stated, "The implementation of Abrimix technology into the various industrial wastewater streams being worked on in the Indian market, will show the capability of the Abrimix technology to improve on the quality of the treated water being produced, and do so cost effectively and consistently within a small footprint treatment plant. The water quality produced with the Abrimix SSF plant is ideal as an effective pretreatment of feed water to a membrane plant to produce potable quality reuse water at an affordable price should the client want to recover the treated water."   

AbriMix Pty Limited創始人兼首席執行官Pieter Jansen表示:“將AbriMix技術應用到印度市場上正在處理的各種工業廢水中,將展示AbriMix技術改善處理後水質量的能力,並在一個佔地面積較小的處理廠內經濟高效且始終如一地做到這一點。如果客户想要回收處理後的水,AbriMix SSF廠生產的水質是膜廠給水的有效預處理,以便以負擔得起的價格生產可飲用的優質再利用水。”

About Lifequest & Biopipe
Lifequest offers effluent treatment plants (ETP), sewage treatment plants (STP), fat oil and grease (FOG) separator and hybrid media for water polishing. Biopipe has developed a patented, 100% sludge-free, chemical-free, odor-free, silent, easy to assemble and install, scalable, low cost, ecological and low maintenance-free onsite sewage wastewater treatment system.  The Abrimix ETP solution available through our joint venture is a highly efficient and cost-effective industrial wastewater treatment system that is vastly superior to Dissolved Air Floatation (DAF) and other onsite industrial wastewater treatment systems.                     

關於LifeQuest&Biopipe
LifeQuest提供污水處理廠(ETP)、污水處理廠(STP)、脂肪和油脂(霧)分離器以及用於水拋光的混合介質。Biopipe已開發出一種專利、100%無污泥、無化學物質、無異味、安靜、易於組裝和安裝、可擴展、低成本、生態和低維護的現場污水處理系統。通過我們的合資企業提供的AbriMix ETP解決方案是一種高效且具有成本效益的工業廢水處理系統,遠遠優於溶解氣浮(DAF)和其他現場工業廢水處理系統。


Contact: tanmay@lifequestcorp.com
Phone: 646-201-5242


聯繫人:tanMay@life questcorp.com
電話:646-201-5242

This press release contains forward-looking statements that reflect the Company's current beliefs, expectations or intentions regarding future events.  Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements.  Words such as "will," "will be", "anticipate," "predict," "expect," "continue," "future," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of the Company and are difficult to predict.  Examples of such risks and uncertainties include, but are not limited to: political unrest in countries we operate in, Covid-19 pandemic related disruptions, shipping constraints, expatriation of invested capital, defaults, future revenues, expenditures, capital, the adequacy of the Company's current cash and working capital to fund present and planned operations, investments and the growth through joint ventures. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, can be found in our current Disclosure Statements at . The Company anticipates that subsequent events and developments may cause views and expectations to change. The Company assumes no obligation, and specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

本新聞稿包含前瞻性陳述,反映了公司目前對未來事件的信念、期望或意圖。本新聞稿中包含的任何非歷史事實的陳述均可被視為前瞻性陳述。諸如“將”、“將是”、“預期”、“預測”、“預期”、“繼續”、“未來”等詞語以及類似的表述旨在識別此類前瞻性陳述。所有前瞻性陳述都涉及重大風險和不確定性,可能導致實際結果與前瞻性陳述中明示或暗示的結果大不相同,其中許多通常不在公司的控制範圍之內,難以預測。此類風險和不確定性的例子包括但不限於:我們開展業務的國家/地區的政治動盪、與新冠肺炎疫情相關的中斷、運輸限制、投資資本的外流、違約、未來的收入、支出、資本、公司目前的現金和營運資本是否足以為目前和計劃中的業務、投資和通過合資企業實現的增長提供資金。其他可能導致實際結果與前瞻性陳述中明示或暗示的結果大不相同的因素,可在我們目前的披露陳述中找到,網址為。該公司預計,後續事件和發展可能會導致觀點和預期發生變化。無論是由於新信息、未來事件或其他原因,公司都不承擔更新任何前瞻性陳述的義務,也不承擔任何意圖或義務。


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論